Uveitis Associated With Pediatric Behçet Disease in the American Midwest

American Journal of Ophthalmology

Volumn 146, Issue 6, 2008, Pages

  Kesen, Muge R ^a   Goldstein, Debra A ^a   Tessler, Howard H ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADALIMUMAB; AZATHIOPRINE; CHLORAMBUCIL; CYCLOPHOSPHAMIDE; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; INFLIXIMAB; METHOTREXATE; PREDNISONE; STEROID;

ADOLESCENT; ADULT; ARTICLE; BEHCET DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; DEMOGRAPHY; DISEASE COURSE; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LABORATORY TEST; MALE; MOUTH ULCER; PATIENT COMPLIANCE; PRIORITY JOURNAL; PROGNOSIS; RETINA MACULOPATHY; RETINA VASCULITIS; RETROSPECTIVE STUDY; SCHOOL CHILD; SYMPTOMATOLOGY; TREATMENT RESPONSE; UVEITIS; VISUAL ACUITY; VISUAL IMPAIRMENT;

EID: 56249112598     PISSN: 00029394     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajo.2008.05.043     Document Type: Article

References (38)

1. O'Duffy J.D. Behçet's disease. Curr Opin Rheumatol 6 (1994) 39-43
2. Japan BsDCo. Behçet's Disease: guide to diagnosis of Behçet's Disease. Jpn J Ophthalmol 18 (1974) 291-294
3. International Study Group for Behçet's Disease. Criteria for diagnosis of Behçet's disease. Lancet 335 (1990) 1078-1080
4. Mishima S., Masuda K., Izawa Y., Mochizuki M., and Namba K. The eighth Frederick H. Verhoeff Lecture. Presented by Saiichi Mishima, MD. Behçet's disease in Japan: ophthalmologic aspects. Trans Am Ophthalmol Soc 77 (1979) 225-279
5. Kone-Paut I., and Bernard J.L. Behçet disease in children in France. Arch Fr Pediatr (French) 50 (1993) 561-565
6. Eldem B., Onur C., and Ozen S. Clinical features of pediatric Behçet's disease. J Pediatr Ophthalmol Strabismus 35 (1998) 159-161
7. Yazici H., Tuzun Y., Pazarli H., et al. Influence of age of onset and patient's sex on the prevalence and severity of manifestations of Behçet's syndrome. Ann Rheum Dis 43 (1984) 783-789
8. Pivetti-Pezzi P., Accorinti M., Abdulaziz M.A., La Cava M., Torella M., and Riso D. Behçet's disease in children. Jpn J Ophthalmol 39 (1995) 309-314
9. Kone-Paut I., Yurdakul S., Bahabri S.A., et al. Clinical features of Behçet's disease in children: an international collaborative study of 86 cases. J Pediatr 132 (1998) 721-725
10. Krause I., Uziel Y., Guedj D., et al. Childhood Behçet's disease: clinical features and comparison with adult-onset disease. Rheumatology (Oxford) 38 (1999) 457-462
11. Jabs D.A., Nussenblatt R.B., and Rosenbaum J.T. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol 140 (2005) 509-516
12. Tugal-Tutkun I., Havrlikova K., Power W.J., and Foster C.S. Changing patterns in uveitis of childhood. Ophthalmology 103 (1996) 375-383
13. Borlu M., Uksal U., Ferahbas A., and Evereklioglu C. Clinical features of Behçet's disease in children. Int J Dermatol 45 (2006) 713-716
14. Lang B.A., Laxer R.M., Thorner P., Greenberg M., and Silverman E.D. Pediatric onset of Behçet's syndrome with myositis: case report and literature review illustrating unusual features. Arthritis Rheum 33 (1990) 418-425
15. Hamdan A., Mansour W., Uthman I., Masri A.F., Nasr F., and Arayssi T. Behçet's disease in Lebanon: clinical profile, severity and two-decade comparison. Clin Rheumatol 25 (2006) 364-367
16. Ozdal P.C., Ortac S., Taskintuna I., and Firat E. Posterior segment involvement in ocular Behçet's disease. Eur J Ophthalmol 12 (2002) 424-431
17. Tugal-Tutkun I., and Urgancioglu M. Childhood-onset uveitis in Behçet disease: a descriptive study of 36 cases. Am J Ophthalmol 136 (2003) 1114-1119
18. Kitaichi N., Miyazaki A., Iwata D., Ohno S., Stanford M.R., and Chams H. Ocular features of Behçet's disease: an international collaborative study. Br J Ophthalmol 91 (2007) 1579-1582
19. Allali F., Benomar A., Karim A., et al. Behçet's disease in Moroccan children: a report of 12 cases. Scand J Rheumatol 33 (2004) 362-363
20. Evereklioglu C., Yurekli M., Er H., et al. Increased plasma adrenomedullin levels in patients with Behçet's disease. Dermatology 201 (2000) 312-315
21. Evereklioglu C., Inaloz H.S., Kirtak N., et al. Serum leptin concentration is increased in patients with Behçet's syndrome and is correlated with disease activity. Br J Dermatol 147 (2002) 331-336
22. Evereklioglu C., Turkoz Y., Er H., Inaloz H.S., Ozbek E., and Cekmen M. Increased nitric oxide production in patients with Behçet's disease: is it a new activity marker?. J Am Acad Dermatol 46 (2002) 50-54
23. Yazici H., Chamberlain M.A., Tuzun Y., Yurdakul S., and Muftuoglu A. A comparative study of the pathergy reaction among Turkish and British patients with Behçet's disease. Ann Rheum Dis 43 (1984) 74-75
24. Dogan B., Taskapan O., and Harmanyeri Y. Prevalance of pathergy test positivity in Behçet's disease in Turkey. J Eur Acad Dermatol Venereol 17 (2003) 228-229
25. Gurler A., Boyvat A., and Tursen U. Clinical manifestations of Behçet's disease: an analysis of 2,147 patients. Yonsei Med J 38 (1997) 423-427
26. Ozdemir M., Bodur S., Engin B., and Baysal I. Evaluation of application of multiple needle pricks on the pathergy reaction. Int J Dermatol 47 (2008) 335-338
27. Mamo J.G. Treatment of Behçet disease with chlorambucil. A follow-up report. Arch Ophthalmol 94 (1976) 580-583
28. Mamo J.G., and Azzam S.A. Treatment of Behçet's disease with chlorambucil. Arch Ophthalmol 84 (1970) 446-450
29. Mudun B.A., Ergen A., Ipcioglu S.U., Burumcek E.Y., Durlu Y., and Arslan M.O. Short-term chlorambucil for refractory uveitis in Behçet's disease. Ocul Immunol Inflamm 9 (2001) 219-229
30. Goldstein D.A., Fontanilla F.A., Kaul S., Sahin O., and Tessler H.H. Long-term follow-up of patients treated with short-term high-dose chlorambucil for sight-threatening ocular inflammation. Ophthalmology 109 (2002) 370-377
31. Tessler H.H., and Jennings T. High-dose short-term chlorambucil for intractable sympathetic ophthalmia and Behçet's disease. Br J Ophthalmol 74 (1990) 353-357
32. Kauppi M.J., Savolainen H.A., Anttila V.J., and Isomaki H.A. Increased risk of leukaemia in patients with juvenile chronic arthritis treated with chlorambucil. Acta Paediatr 85 (1996) 248-250
33. Palmer R.G., and Denman A.M. Malignancies induced by chlorambucil. Cancer Treat Rev 11 (1984) 121-129
34. Rosenbaum J.T. Blind insight: eyeing anti-tumor necrosis factor treatment in uveitis associated with Behçet's disease. J Rheumatol 31 (2004) 1241-1243
35. Sfikakis P.P., Markomichelakis N., Alpsoy E., et al. Anti-TNF therapy in the management of Behçet's disease-review and basis for recommendations. Rheumatology (Oxford) 46 (2007) 736-741
36. Guillaume-Czitrom S., Berger C., Pajot C., Bodaghi B., Wechsler B., and Kone-Paut I. Efficacy and safety of interferon-alpha in the treatment of corticodependent uveitis of paediatric Behçet's disease. Rheumatology (Oxford) 46 (2007) 1570-1573
37. Pivetti-Pezzi P., Accorinti M., Pirraglia M.P., Priori R., and Valesini G. Interferon alpha for ocular Behçet's disease. Acta Ophthalmol Scand 75 (1997) 720-722
38. Kotter I., Zierhut M., Eckstein A.K., et al. Human recombinant interferon alfa-2a for the treatment of Behçet's disease with sight threatening posterior or panuveitis. Br J Ophthalmol 87 (2003) 423-431